1AD1 logo

AddLife AB (publ)DB:1AD1 Stock Report

Market Cap €1.9b
Share Price
€15.36
My Fair Value
AN
AnalystConsensusTarget
€17
10.3% undervalued intrinsic discount
1Y14.1%
7D-0.3%
Portfolio Value
View

AddLife AB (publ)

DB:1AD1 Stock Report

Market Cap: €1.9b

AddLife (1AD1) Stock Overview

Provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. More details

1AD1 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth3/6
Past Performance4/6
Financial Health2/6
Dividends0/6

1AD1 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

AddLife AB (publ) Competitors

Price History & Performance

Summary of share price highs, lows and changes for AddLife
Historical stock prices
Current Share PriceSEK 15.36
52 Week HighSEK 17.91
52 Week LowSEK 10.99
Beta1.61
1 Month Change-8.52%
3 Month Change-7.25%
1 Year Change14.12%
3 Year Change-6.57%
5 Year Change28.86%
Change since IPO141.89%

Recent News & Updates

Recent updates

Shareholder Returns

1AD1DE Life SciencesDE Market
7D-0.3%-4.0%1.7%
1Y14.1%-30.4%20.1%

Return vs Industry: 1AD1 exceeded the German Life Sciences industry which returned -29.2% over the past year.

Return vs Market: 1AD1 underperformed the German Market which returned 18.6% over the past year.

Price Volatility

Is 1AD1's price volatile compared to industry and market?
1AD1 volatility
1AD1 Average Weekly Movement3.9%
Life Sciences Industry Average Movement8.4%
Market Average Movement5.2%
10% most volatile stocks in DE Market12.6%
10% least volatile stocks in DE Market2.7%

Stable Share Price: 1AD1 has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: 1AD1's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19062,322Fredrik Dalborgwww.add.life

AddLife AB (publ), together with its subsidiaries, provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates through Labtech and Medtech segments. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory analysis equipment.

AddLife AB (publ) Fundamentals Summary

How do AddLife's earnings and revenue compare to its market cap?
1AD1 fundamental statistics
Market cap€1.89b
Earnings (TTM)€30.15m
Revenue (TTM)€934.35m
62.5x
P/E Ratio
2.0x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1AD1 income statement (TTM)
RevenueSEK 10.44b
Cost of RevenueSEK 6.50b
Gross ProfitSEK 3.95b
Other ExpensesSEK 3.61b
EarningsSEK 337.00m

Last Reported Earnings

Jun 30, 2025

Next Earnings Date

Oct 23, 2025

Earnings per share (EPS)2.77
Gross Margin37.79%
Net Profit Margin3.23%
Debt/Equity Ratio85.7%

How did 1AD1 perform over the long term?

See historical performance and comparison

Dividends

0.4%
Current Dividend Yield
27%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/07/31 10:22
End of Day Share Price 2025/07/31 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

AddLife AB (publ) is covered by 3 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Karl NorénDanske Bank
Robert RedinDNB Carnegie
Gustav BernebladNordea Markets